Article
Cutting Edge Molecular Therapy for Acute Myeloid Leukemia.
International journal of molecular sciences - 20 Jul 2020
Miyamoto Kenichi, Minami Yosuke
Abstract excerpt
Recently, whole exome sequencing for acute myeloid leukemia (AML) has been performed by a next-generation sequencer in several studies. It has been revealed that a few gene mutations are identified per AML patient. Some of these mutations are actionable mutations that affect the response to an approved targeted treatment that is available for off-label treatment or that is available in clinical trials. The era of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
